Literature DB >> 19181541

The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.

B Krämer1, H Schildger, H A Behrensdorf-Nicol, K M Hanschmann, K Duchow.   

Abstract

The European Pharmacopoeia proposes two methods for potency determination of inactivated rabies vaccines for veterinary use: The first one is a classical mouse challenge test, which is imprecise, time-consuming, and causes severe distress to the test animals. Alternatively, the potency may be determined serologically by measuring the neutralizing antibody titers induced after vaccination of mice by using a rapid fluorescent focus inhibition test (RFFIT). Although this method is faster and less painful for the animals, it is not widely used yet, and only little data exist concerning the comparability of both methods. We have therefore performed a comparative study, in which we demonstrated a good correlation between the challenge test results and the mean titers determined by RFFIT. Furthermore, all vaccine batches failing the challenge test were also recognized as insufficient in the serological assay. This publication further describes the influence of different vaccine administration routes on the resulting antibody titers, and it proposes various modifications to the serological assay protocol which could improve its overall practicability. Finally, we recommend that the serological assay be used for the potency testing of inactivated rabies vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181541     DOI: 10.1016/j.biologicals.2009.01.001

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  9 in total

1.  Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.

Authors:  Renata da Fontoura Budaszewski; Andrew Hudacek; Bevan Sawatsky; Beate Krämer; Xiangping Yin; Matthias J Schnell; Veronika von Messling
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.

Authors:  Ye Liu; Shoufeng Zhang; Fei Zhang; Rongliang Hu
Journal:  Virol Sin       Date:  2012-07-28       Impact factor: 4.327

3.  Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.

Authors:  Sarah Moeschler; Samira Locher; Karl-Klaus Conzelmann; Beate Krämer; Gert Zimmer
Journal:  Viruses       Date:  2016-09-16       Impact factor: 5.048

4.  A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.

Authors:  Guanfeng Lin; Shaolang Chen; Hui Zhao; Junyu Liang; Qiaoting Deng; Rongliang Liang; Xinxin Guo; Zhenhua Chen; Baihong Chen; Tiancai Liu; Yingsong Wu
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

5.  Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies.

Authors:  Irina Matveeva; Olga Karpova; Nikolai Nikitin; Oleg Akilin; Vasiliy Yelnikov; Irina Litenkova; Roman Melnik; Nikolai Melnik; Karim Asimov; Aleksey Zaberezhny; Yriy Fyodorov; Evgeniya Markova
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

6.  Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions.

Authors:  Jodie Kulpa-Eddy; Geetha Srinivas; Marlies Halder; Richard Hill; Karen Brown; James Roth; Hans Draayer; Jeffrey Galvin; Ivo Claassen; Glen Gifford; Ralph Woodland; Vivian Doelling; Brett Jones; William S Stokes
Journal:  Procedia Vaccinol       Date:  2011-12-23

7.  Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.

Authors:  Hirofumi Kato; Mutsuyo Takayama-Ito; Itoe Iizuka-Shiota; Shuetsu Fukushi; Guillermo Posadas-Herrera; Madoka Horiya; Masaaki Satoh; Tomoki Yoshikawa; Souichi Yamada; Shizuko Harada; Hikaru Fujii; Miho Shibamura; Takuya Inagaki; Kinjiro Morimoto; Masayuki Saijo; Chang-Kweng Lim
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240

8.  Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection.

Authors:  Beatriz Lourenço Correia Moreira; Ana Paula Lappas Gimenez; Jorge Minor Fernandes Inagaki; Sonia Mara Raboni
Journal:  PLoS Negl Trop Dis       Date:  2020-03-25

9.  A Comparative Evaluation of the Estimation of Rabies Virus Antibodies among Free-Roaming, Vaccinated Dogs in Bengaluru, India.

Authors:  Lekshmi J Das; Shrikrishna Isloor; Alur Kotrappa Santosh; Avinash Bhat; Ramakrishnaiah Sharada; Doddamane Rathnamma; Belamaranahally Muniveerappa Veeregowda; Konanduru Lingappa Phaniraj; Nageshkumar Abhijit Kumar; Abi T Vanak
Journal:  Viruses       Date:  2022-02-26       Impact factor: 5.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.